ID   COE3_HUMAN              Reviewed;         596 AA.
AC   Q9H4W6; A0AUY1; Q5T6H9; Q9H4W5;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 2.
DT   07-APR-2021, entry version 169.
DE   RecName: Full=Transcription factor COE3;
DE   AltName: Full=Early B-cell factor 3;
DE            Short=EBF-3;
DE   AltName: Full=Olf-1/EBF-like 2;
DE            Short=O/E-2;
DE            Short=OE-2;
GN   Name=EBF3; Synonyms=COE3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS LONG AND SHORT).
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12355068; DOI=10.1038/ng1007;
RA   Zardo G., Tiirikainen M.I., Hong C., Misra A., Feuerstein B.G., Volik S.,
RA   Collins C.C., Lamborn K.R., Bollen A., Pinkel D., Albertson D.G.,
RA   Costello J.F.;
RT   "Integrated genomic and epigenomic analyses pinpoint biallelic gene
RT   inactivation in tumors.";
RL   Nat. Genet. 32:453-458(2002).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 261-415.
RX   PubMed=20592035; DOI=10.1074/jbc.c110.150482;
RA   Siponen M.I., Wisniewska M., Lehtio L., Johansson I., Svensson L.,
RA   Raszewski G., Nilsson L., Sigvardsson M., Berglund H.;
RT   "Structural determination of functional domains in early B-cell factor
RT   (EBF) family of transcription factors reveals similarities to Rel DNA-
RT   binding proteins and a novel dimerization motif.";
RL   J. Biol. Chem. 285:25875-25879(2010).
RN   [6]
RP   VARIANTS HADDS ASP-66; CYS-141; HIS-GLU-ILE-159 INS; ASP-171; LEU-177 AND
RP   TRP-209, CHARACTERIZATION OF VARIANTS HADDS ASP-66; CYS-141;
RP   HIS-GLU-ILE-159 INS; ASP-171; LEU-177 AND TRP-209, INVOLVEMENT IN HADDS,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=28017373; DOI=10.1016/j.ajhg.2016.11.012;
RA   Harms F.L., Girisha K.M., Hardigan A.A., Kortuem F., Shukla A., Alawi M.,
RA   Dalal A., Brady L., Tarnopolsky M., Bird L.M., Ceulemans S., Bebin M.,
RA   Bowling K.M., Hiatt S.M., Lose E.J., Primiano M., Chung W.K., Juusola J.,
RA   Akdemir Z.C., Bainbridge M., Charng W.L., Drummond-Borg M., Eldomery M.K.,
RA   El-Hattab A.W., Saleh M.A., Bezieau S., Cogne B., Isidor B., Kuery S.,
RA   Lupski J.R., Myers R.M., Cooper G.M., Kutsche K.;
RT   "Mutations in EBF3 disturb transcriptional profiles and cause intellectual
RT   disability, ataxia, and facial dysmorphism.";
RL   Am. J. Hum. Genet. 100:117-127(2017).
RN   [7]
RP   VARIANTS HADDS GLN-163 AND LEU-163, CHARACTERIZATION OF VARIANTS HADDS
RP   GLN-163 AND LEU-163, AND FUNCTION.
RX   PubMed=28017372; DOI=10.1016/j.ajhg.2016.11.018;
RA   Chao H.T., Davids M., Burke E., Pappas J.G., Rosenfeld J.A., McCarty A.J.,
RA   Davis T., Wolfe L., Toro C., Tifft C., Xia F., Stong N., Johnson T.K.,
RA   Warr C.G., Yamamoto S., Adams D.R., Markello T.C., Gahl W.A., Bellen H.J.,
RA   Wangler M.F., Malicdan M.C.;
RT   "A syndromic neurodevelopmental disorder caused by de novo variants in
RT   EBF3.";
RL   Am. J. Hum. Genet. 100:128-137(2017).
RN   [8]
RP   VARIANTS HADDS PRO-163; LEU-177 AND ASN-193, CHARACTERIZATION OF VARIANTS
RP   HADDS PRO-163; LEU-177 AND ASN-193, AND FUNCTION.
RX   PubMed=28017370; DOI=10.1016/j.ajhg.2016.11.020;
RA   Sleven H., Welsh S.J., Yu J., Churchill M.E., Wright C.F., Henderson A.,
RA   Horvath R., Rankin J., Vogt J., Magee A., McConnell V., Green A.,
RA   King M.D., Cox H., Armstrong L., Lehman A., Nelson T.N., Williams J.,
RA   Clouston P., Hagman J., Nemeth A.H.;
RT   "De novo mutations in EBF3 cause a neurodevelopmental syndrome.";
RL   Am. J. Hum. Genet. 100:138-150(2017).
CC   -!- FUNCTION: Transcriptional activator (PubMed:28017373, PubMed:28017372,
CC       PubMed:28017370). Recognizes variations of the palindromic sequence 5'-
CC       ATTCCCNNGGGAATT-3' (By similarity). {ECO:0000250|UniProtKB:Q07802,
CC       ECO:0000269|PubMed:28017370, ECO:0000269|PubMed:28017372,
CC       ECO:0000269|PubMed:28017373}.
CC   -!- SUBUNIT: Forms either a homodimer or a heterodimer with a related
CC       family member. {ECO:0000250|UniProtKB:O08791}.
CC   -!- INTERACTION:
CC       Q9H4W6-2; Q8N5M1: ATPAF2; NbExp=3; IntAct=EBI-17233744, EBI-1166928;
CC       Q9H4W6-2; Q9HAK2: EBF2; NbExp=3; IntAct=EBI-17233744, EBI-12267154;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28017373}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9H4W6-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q9H4W6-2; Sequence=VSP_001113, VSP_001114;
CC   -!- TISSUE SPECIFICITY: Expressed in brain. {ECO:0000269|PubMed:12355068}.
CC   -!- DISEASE: Hypotonia, ataxia, and delayed development syndrome (HADDS)
CC       [MIM:617330]: An autosomal dominant neurodevelopmental syndrome
CC       characterized by global developmental delay, moderate to severe
CC       intellectual disability, cerebellar ataxia, hypotonia, speech delay,
CC       variable dysmorphic features, and genitourinary abnormalities including
CC       vesicoureteric reflux. {ECO:0000269|PubMed:28017370,
CC       ECO:0000269|PubMed:28017372, ECO:0000269|PubMed:28017373}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the COE family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL354950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49160.1; -; Genomic_DNA.
DR   EMBL; BC126130; AAI26131.1; -; mRNA.
DR   EMBL; BC130479; AAI30480.1; -; mRNA.
DR   CCDS; CCDS31314.1; -. [Q9H4W6-2]
DR   RefSeq; NP_001005463.1; NM_001005463.2. [Q9H4W6-2]
DR   RefSeq; XP_005252725.1; XM_005252668.3.
DR   PDB; 3MUJ; X-ray; 1.92 A; A/B=261-395.
DR   PDB; 3N50; X-ray; 3.10 A; A/B/C/D/E/F=261-415.
DR   PDBsum; 3MUJ; -.
DR   PDBsum; 3N50; -.
DR   SMR; Q9H4W6; -.
DR   BioGRID; 128985; 13.
DR   IntAct; Q9H4W6; 7.
DR   MINT; Q9H4W6; -.
DR   STRING; 9606.ENSP00000357637; -.
DR   iPTMnet; Q9H4W6; -.
DR   PhosphoSitePlus; Q9H4W6; -.
DR   BioMuta; EBF3; -.
DR   DMDM; 13959320; -.
DR   MassIVE; Q9H4W6; -.
DR   MaxQB; Q9H4W6; -.
DR   PeptideAtlas; Q9H4W6; -.
DR   PRIDE; Q9H4W6; -.
DR   ProteomicsDB; 80876; -. [Q9H4W6-1]
DR   ProteomicsDB; 80877; -. [Q9H4W6-2]
DR   Antibodypedia; 32510; 181 antibodies.
DR   Ensembl; ENST00000355311; ENSP00000347463; ENSG00000108001. [Q9H4W6-1]
DR   Ensembl; ENST00000368648; ENSP00000357637; ENSG00000108001. [Q9H4W6-2]
DR   GeneID; 253738; -.
DR   KEGG; hsa:253738; -.
DR   UCSC; uc001lki.3; human. [Q9H4W6-1]
DR   CTD; 253738; -.
DR   DisGeNET; 253738; -.
DR   GeneCards; EBF3; -.
DR   HGNC; HGNC:19087; EBF3.
DR   HPA; ENSG00000108001; Tissue enhanced (breast, lymphoid tissue).
DR   MalaCards; EBF3; -.
DR   MIM; 607407; gene.
DR   MIM; 617330; phenotype.
DR   neXtProt; NX_Q9H4W6; -.
DR   OpenTargets; ENSG00000108001; -.
DR   PharmGKB; PA134972607; -.
DR   VEuPathDB; HostDB:ENSG00000108001.13; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   GeneTree; ENSGT00950000182859; -.
DR   HOGENOM; CLU_016320_3_1_1; -.
DR   InParanoid; Q9H4W6; -.
DR   OMA; YPSAGPR; -.
DR   OrthoDB; 817293at2759; -.
DR   PhylomeDB; Q9H4W6; -.
DR   TreeFam; TF313391; -.
DR   PathwayCommons; Q9H4W6; -.
DR   SIGNOR; Q9H4W6; -.
DR   BioGRID-ORCS; 253738; 5 hits in 1010 CRISPR screens.
DR   ChiTaRS; EBF3; human.
DR   EvolutionaryTrace; Q9H4W6; -.
DR   GenomeRNAi; 253738; -.
DR   Pharos; Q9H4W6; Tbio.
DR   PRO; PR:Q9H4W6; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9H4W6; protein.
DR   Bgee; ENSG00000108001; Expressed in gastrocnemius and 164 other tissues.
DR   ExpressionAtlas; Q9H4W6; baseline and differential.
DR   Genevisible; Q9H4W6; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd11606; COE_DBD; 1.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 2.60.40.3180; -; 1.
DR   Gene3D; 4.10.280.10; -; 2.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR038173; COE_DBD_sf.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Developmental protein;
KW   Disease variant; DNA-binding; Mental retardation; Metal-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..596
FT                   /note="Transcription factor COE3"
FT                   /id="PRO_0000107832"
FT   DOMAIN          263..346
FT                   /note="IPT/TIG"
FT   ZN_FING         151..170
FT                   /note="C5-type"
FT                   /evidence="ECO:0000255"
FT   REGION          63..66
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          197..204
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          236..239
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        464..555
FT                   /note="Pro/Ser/Thr-rich"
FT   SITE            163
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            172
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         252..260
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001113"
FT   VAR_SEQ         521..558
FT                   /note="IVPSSPTMAASSVTLPSNCSSTHGIFSFSPANVISAVK -> MK (in
FT                   isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001114"
FT   VARIANT         66
FT                   /note="N -> D (in HADDS; significant loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin binding;
FT                   dbSNP:rs1057519518)"
FT                   /evidence="ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078033"
FT   VARIANT         141
FT                   /note="Y -> C (in HADDS; significant loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin-binding;
FT                   dbSNP:rs1057519519)"
FT                   /evidence="ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078034"
FT   VARIANT         159
FT                   /note="I -> IHEI (in HADDS; significant loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin-binding)"
FT                   /evidence="ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078035"
FT   VARIANT         163
FT                   /note="R -> L (in HADDS; partial loss of transcriptional
FT                   activator activity; dbSNP:rs1057519389)"
FT                   /evidence="ECO:0000269|PubMed:28017372"
FT                   /id="VAR_078036"
FT   VARIANT         163
FT                   /note="R -> P (in HADDS; loss of transcriptional activator
FT                   activity; dbSNP:rs1057519389)"
FT                   /evidence="ECO:0000269|PubMed:28017370"
FT                   /id="VAR_078037"
FT   VARIANT         163
FT                   /note="R -> Q (in HADDS; loss of transcriptional activator
FT                   activity; dbSNP:rs1057519389)"
FT                   /evidence="ECO:0000269|PubMed:28017372"
FT                   /id="VAR_078038"
FT   VARIANT         171
FT                   /note="G -> D (in HADDS; significant loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin-binding;
FT                   dbSNP:rs1057519437)"
FT                   /evidence="ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078039"
FT   VARIANT         177
FT                   /note="P -> L (in HADDS; according to PubMed:28017373 shows
FT                   significant loss of transcriptional activator activity
FT                   while according to PubMed:28017370 shows partial loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin-binding;
FT                   dbSNP:rs869312668)"
FT                   /evidence="ECO:0000269|PubMed:28017370,
FT                   ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078040"
FT   VARIANT         193
FT                   /note="K -> N (in HADDS; significant loss of
FT                   transcriptional activator activity; dbSNP:rs1057519520)"
FT                   /evidence="ECO:0000269|PubMed:28017370"
FT                   /id="VAR_078041"
FT   VARIANT         209
FT                   /note="R -> W (in HADDS; significant loss of
FT                   transcriptional activator activity; localizes both in the
FT                   cytoplasm and the nucleus; decreased chromatin-binding;
FT                   dbSNP:rs779003155)"
FT                   /evidence="ECO:0000269|PubMed:28017373"
FT                   /id="VAR_078042"
FT   STRAND          264..274
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          280..287
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          293..296
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          299..301
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          303..307
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          310..314
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          322..330
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          333..335
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   STRAND          337..339
FT                   /evidence="ECO:0007744|PDB:3N50"
FT   STRAND          341..346
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   HELIX           353..363
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   HELIX           376..391
FT                   /evidence="ECO:0007744|PDB:3MUJ"
FT   HELIX           396..412
FT                   /evidence="ECO:0007744|PDB:3N50"
SQ   SEQUENCE   596 AA;  64864 MW;  EE5C9D10CD3DED02 CRC64;
     MFGIQENIPR GGTTMKEEPL GSGMNPVRSW MHTAGVVDAN TAAQSGVGLA RAHFEKQPPS
     NLRKSNFFHF VLALYDRQGQ PVEIERTAFV DFVEKEKEPN NEKTNNGIHY KLQLLYSNGV
     RTEQDLYVRL IDSMTKQAIV YEGQDKNPEM CRVLLTHEIM CSRCCDKKSC GNRNETPSDP
     VIIDRFFLKF FLKCNQNCLK NAGNPRDMRR FQVVVSTTVN VDGHVLAVSD NMFVHNNSKH
     GRRARRLDPS EGTAPSYLEN ATPCIKAISP SEGWTTGGAT VIIIGDNFFD GLQVVFGTML
     VWSELITPHA IRVQTPPRHI PGVVEVTLSY KSKQFCKGAP GRFVYTALNE PTIDYGFQRL
     QKVIPRHPGD PERLPKEVLL KRAADLVEAL YGMPHNNQEI ILKRAADIAE ALYSVPRNHN
     QIPTLGNNPA HTGMMGVNSF SSQLAVNVSE TSQANDQVGY SRNTSSVSPR GYVPSSTPQQ
     SNYNTVSTSM NGYGSGAMAS LGVPGSPGFL NGSSANSPYG IVPSSPTMAA SSVTLPSNCS
     STHGIFSFSP ANVISAVKQK SAFAPVVRPQ ASPPPSCTSA NGNGLQAMSG LVVPPM
//
